Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178118 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Elisabet Cantó und 12 weiteren Autor:innen. Beteiligte Einrichtung: Group of Inflammatory Diseases, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Psoriasis, Transcriptome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psoriasis is a chronic inflammatory skin disease driven by genetic, environmental, and immune factors. While biologics like adalimumab (anti-TNFα) and risankizumab (anti-IL-23) have improved outcomes, patient response variability remains unclear. This study examined immune-related transcriptomic differences between lesional (L) and non-lesional (NL) psoriatic skin, focusing on immune-related hub genes, their plasma levels, and their correlations with severity and treatment response. Patients with moderate-to-severe psoriasis were enrolled before treatment with anti-TNFα (n = 16) or anti-IL-23 (n = 18). Plasma and paired L and NL skin biopsies were collected for RNA sequencing. Gene ontology enrichment analysis found four immune-related terms enriched in L skin: T-helper 17, granulocyte and lymphocyte chemotaxis, and antimicrobial humoral response. A protein–protein interaction network identified ten immune-related hub genes upregulated in L skin that correlated with clinical severity. Patients with prior treatments expressed distinctive gene profiles. Plasma levels of CCL20 strongly correlated with disease severity. Decision tree models identified CCL20 expression in skin and plasma levels of IL-6 and CXCL8 as candidate predictors for anti-TNFα response. Similarly, skin expression of CXCL8, IL-6, and CXCL10, alongside plasma levels of CCL20, IL-6, and CXCL8, may predict anti-IL-23 response. Ten immune-related hubs may serve as possible biomarkers for disease severity and therapeutic response in psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Group of Inflammatory Diseases, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
- Dermatology Unit, Hospital Quirónsalud, 50012 Zaragoza, Spain.
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
- Dermatology Unit, Hospital Royo Villanova, 50015 Zaragoza, Spain.
- Centro Nacional de Analisis Genomico (CNAG), 08028 Barcelona, Spain.
- Universitat de Barcelona (UB), 08036 Barcelona, Spain.
ORCID-Profile: Anna López-Ferrer, Maria Angels Ortiz, Marta Gut, Maria Mulet, Anna Esteve-Codina, Ruben Osuna-Gómez, Albert Guinart-Cuadra, Luís Puig, Silvia Vidal
Zitieren
APA
Cantó, E., Del Prado, M. E., Vilarrasa, E., López-Ferrer, A., García Latasa de Araníbar, F. J., Ortiz, M. A., Gut, M., Mulet, M., Esteve-Codina, A., Osuna-Gómez, R., Guinart-Cuadra, A., Puig, L., & Vidal, S. (2025). Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178118
Vancouver
Cantó E, Del Prado ME, Vilarrasa E, López-Ferrer A, García Latasa de Araníbar FJ, Ortiz MA, et al. Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178118
BibTeX
@article{Cant2025,
author = {Cantó, Elisabet and Del Prado, María Elena and Vilarrasa, Eva and López-Ferrer, Anna and García Latasa de Araníbar, Francisco Javier and Ortiz, Maria Angels and Gut, Marta and Mulet, Maria and Esteve-Codina, Anna and Osuna-Gómez, Ruben and Guinart-Cuadra, Albert and Puig, Luís and Vidal, Silvia},
title = {Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178118}
}
EUVIMED